Search - tctmd.com

Displaying 21 - 40 of 89

Sort: Relevancy | Date

News Daily News

Elevated LDL Cholesterol in Mom, Increased LDL Cholesterol in Adult Offspring, Irrespective of Genetics

Michael O'Riordan

March 01, 2016

News Daily News

‘Negative’ Atherosclerotic Imaging Results Shift 10-Year CVD Risk Downward: MESA Analysis

Michael O'Riordan

January 28, 2016

News Daily News

PCI for Cardiogenic Shock: Mortality Has Increased, but So Has Patient Risk

Yael L. Maxwell

January 20, 2016

News Daily News

Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128

Caitlin E. Cox

December 20, 2015

News Daily News

Younger Women With STEMI More Likely Than Men to Die In-Hospital

L.A. McKeown

October 28, 2015

News Industry News

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

September 28, 2015

News Daily News

Public Reporting of PCI Mortality Tied to Fewer High-Risk Cases But Better Outcomes

September 24, 2015

News Industry News

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

August 20, 2015

News Daily News

Elective EVAR Yielding Better Short-Term Results at Lower Cost Than Before

Todd Neale

August 20, 2015

News Daily News

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

August 06, 2015

News Industry News

Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia

July 24, 2015

News Industry News

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

July 21, 2015

News Daily News

Older Age Tied to Higher Risk of Recurrent Cerebral Ischemia in PFO Closure Patients

Yael L. Maxwell

July 08, 2015

News Daily News

Acute MI Arising From Coronary Embolism Rare, Often Tied to A-fib

L.A. McKeown

July 08, 2015

News Industry News

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

June 05, 2015

News Daily News

Cardiac Rehab Referral Low, Inconsistent Across US Hospitals

Yael L. Maxwell

May 13, 2015

News Industry News

New Meta-Analysis On Pitavastatin Demonstrates No Adverse Effect Compared With Placebo Or Other Statins On New-Onset Diabetes In Non-Diabetic Patients At Risk For Cardiovascular Disease

May 04, 2015

News Daily News

Registry Finds No Stark Differences Between Proximal, Distal Embolic Protection in CAS

Caitlin E. Cox

April 28, 2015

News Daily News

Recommendations Tackle Hypertension in CAD Patients

Todd Neale

April 03, 2015

News Daily News

Poor Responders to Statins at Risk for CAD Progression

March 11, 2015

Advertisement

Elevated LDL Cholesterol in Mom, Increased LDL Cholesterol in Adult Offspring, Irrespective of Genetics

‘Negative’ Atherosclerotic Imaging Results Shift 10-Year CVD Risk Downward: MESA Analysis

PCI for Cardiogenic Shock: Mortality Has Increased, but So Has Patient Risk

Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128

Younger Women With STEMI More Likely Than Men to Die In-Hospital

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

Public Reporting of PCI Mortality Tied to Fewer High-Risk Cases But Better Outcomes

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

Elective EVAR Yielding Better Short-Term Results at Lower Cost Than Before

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

Older Age Tied to Higher Risk of Recurrent Cerebral Ischemia in PFO Closure Patients

Acute MI Arising From Coronary Embolism Rare, Often Tied to A-fib

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

Cardiac Rehab Referral Low, Inconsistent Across US Hospitals

New Meta-Analysis On Pitavastatin Demonstrates No Adverse Effect Compared With Placebo Or Other Statins On New-Onset Diabetes In Non-Diabetic Patients At Risk For Cardiovascular Disease

Registry Finds No Stark Differences Between Proximal, Distal Embolic Protection in CAS

Recommendations Tackle Hypertension in CAD Patients

Poor Responders to Statins at Risk for CAD Progression

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content